Trials / Completed
CompletedNCT00164008
Comparison of Pamidronate With Zoledronic Acid for Transplant Related Bone Loss Prevention
Comparison Between Pamidronate and Zoledronic Acid for the Treatment of Heart and Lung Transplant Related Osteopaenia and Osteoporosis
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 56 (actual)
- Sponsor
- Bayside Health · Other Government
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this trial is to see whether zoledronic acid is better than pamidronate to treat low bone density in heart and lung transplant patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | zoledronic acid vs pamidronate |
Timeline
- Start date
- 2002-10-01
- Primary completion
- 2005-12-01
- Completion
- 2005-12-01
- First posted
- 2005-09-14
- Last updated
- 2013-12-05
Source: ClinicalTrials.gov record NCT00164008. Inclusion in this directory is not an endorsement.